chr7_+_116166346
|
2.891
|
NM_001172896
NM_001172897
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
chr7_+_116165043
|
2.872
|
NM_001172895
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
chr7_+_116164838
|
2.850
|
NM_001753
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
chr5_-_151066492
|
1.902
|
NM_003118
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
chr2_-_1748285
|
1.784
|
NM_012293
|
PXDN
|
peroxidasin homolog (Drosophila)
|
chr8_-_41166931
|
1.511
|
NM_003012
|
SFRP1
|
secreted frizzled-related protein 1
|
chr8_-_49833823
|
1.399
|
NM_003068
|
SNAI2
|
snail homolog 2 (Drosophila)
|
chr7_+_155089483
|
1.370
|
NM_005542
NM_198336
NM_198337
|
INSIG1
|
insulin induced gene 1
|
chr4_+_47487230
|
1.285
|
NM_020453
|
ATP10D
|
ATPase, class V, type 10D
|
chr7_+_116140097
|
1.217
|
NM_001206748
|
CAV2
|
caveolin 2
|
chr7_+_116139619
|
1.207
|
NM_001206747
NM_001233
NM_198212
|
CAV2
|
caveolin 2
|
chr10_+_112257624
|
1.107
|
NM_004419
|
DUSP5
|
dual specificity phosphatase 5
|
chr12_+_4382882
|
1.101
|
NM_001759
|
CCND2
|
cyclin D2
|
chr12_-_106533810
|
1.028
|
NM_014840
|
NUAK1
|
NUAK family, SNF1-like kinase, 1
|
chr4_+_4387982
|
1.014
|
NM_001040101
NM_014392
|
D4S234E
|
DNA segment on chromosome 4 (unique) 234 expressed sequence
|
chr10_-_105845619
|
1.010
|
NM_000494
|
COL17A1
|
collagen, type XVII, alpha 1
|
chr4_+_78078332
|
0.996
|
NM_004354
|
CCNG2
|
cyclin G2
|
chr21_+_39628663
|
0.959
|
NM_002243
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15
|
chr18_+_56530060
|
0.943
|
NM_018181
|
ZNF532
|
zinc finger protein 532
|
chr4_-_143767603
|
0.927
|
NM_001101669
NM_003866
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa
|
chr15_-_63674074
|
0.916
|
NM_001218
NM_206925
|
CA12
|
carbonic anhydrase XII
|
chr5_-_148442606
|
0.914
|
NM_024577
|
SH3TC2
|
SH3 domain and tetratricopeptide repeats 2
|
chr9_-_14398981
|
0.898
|
NM_001190738
|
NFIB
|
nuclear factor I/B
|
chr18_-_21852189
|
0.893
|
NM_018030
|
OSBPL1A
|
oxysterol binding protein-like 1A
|
chr21_+_39628869
|
0.892
|
NM_170736
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15
|
chr18_-_21891469
|
0.863
|
NM_001242508
|
OSBPL1A
|
oxysterol binding protein-like 1A
|
chr12_-_76425375
|
0.853
|
NM_007350
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1
|
chr18_-_53255734
|
0.852
|
NM_001083962
NM_001243230
NM_003199
|
TCF4
|
transcription factor 4
|
chr13_-_110438896
|
0.844
|
NM_003749
|
IRS2
|
insulin receptor substrate 2
|
chr18_-_28622624
|
0.844
|
NM_001941
NM_024423
|
DSC3
|
desmocollin 3
|
chr18_-_21977785
|
0.842
|
NM_080597
|
OSBPL1A
|
oxysterol binding protein-like 1A
|
chr5_+_49961732
|
0.793
|
NM_001178055
|
PARP8
|
poly (ADP-ribose) polymerase family, member 8
|
chr9_-_14314036
|
0.791
|
NM_001190737
NM_005596
|
NFIB
|
nuclear factor I/B
|
chr14_+_85996454
|
0.791
|
NM_013231
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2
|
chr1_+_178310605
|
0.781
|
NM_004841
|
RASAL2
|
RAS protein activator like 2
|
chr13_-_110959441
|
0.744
|
NM_001845
|
COL4A1
|
collagen, type IV, alpha 1
|
chr5_+_49962771
|
0.742
|
NM_001178056
NM_024615
|
PARP8
|
poly (ADP-ribose) polymerase family, member 8
|
chr14_-_75078669
|
0.732
|
NM_000428
|
LTBP2
|
latent transforming growth factor beta binding protein 2
|
chr10_+_11059854
|
0.716
|
NM_006561
|
CELF2
|
CUGBP, Elav-like family member 2
|
chr18_+_9708187
|
0.690
|
NM_006868
|
RAB31
|
RAB31, member RAS oncogene family
|
chr8_-_22550057
|
0.687
|
NM_001199881
|
EGR3
|
early growth response 3
|
chr8_-_22549901
|
0.676
|
NM_001199880
|
EGR3
|
early growth response 3
|
chr1_+_198125890
|
0.675
|
NM_133494
|
NEK7
|
NIMA (never in mitosis gene a)-related kinase 7
|
chr11_-_26743545
|
0.672
|
NM_178498
|
SLC5A12
|
solute carrier family 5 (sodium/glucose cotransporter), member 12
|
chr21_+_39644428
|
0.669
|
NM_170737
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15
|
chrX_+_73641084
|
0.665
|
NM_006517
|
SLC16A2
|
solute carrier family 16, member 2 (monocarboxylic acid transporter 8)
|
chr16_-_17564737
|
0.662
|
NM_022166
|
XYLT1
|
xylosyltransferase I
|
chr10_+_11206928
|
0.662
|
NM_001025076
NM_001083591
|
CELF2
|
CUGBP, Elav-like family member 2
|
chr8_-_22550708
|
0.652
|
NM_004430
|
EGR3
|
early growth response 3
|
chr10_+_11047253
|
0.651
|
NM_001025077
|
CELF2
|
CUGBP, Elav-like family member 2
|
chr15_-_52821004
|
0.647
|
NM_000259
NM_001142495
|
MYO5A
|
myosin VA (heavy chain 12, myoxin)
|
chr8_-_116681103
|
0.643
|
NM_014112
|
TRPS1
|
trichorhinophalangeal syndrome I
|
chr17_+_48610045
|
0.641
|
NM_017957
|
EPN3
|
epsin 3
|
chr3_+_62305395
|
0.638
|
NM_020685
|
C3orf14
|
chromosome 3 open reading frame 14
|
chrX_-_112066353
|
0.632
|
NM_001113490
|
AMOT
|
angiomotin
|
chr9_-_117880411
|
0.629
|
NM_002160
|
TNC
|
tenascin C
|
chr11_+_13299260
|
0.626
|
NM_001030272
NM_001030273
NM_001178
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
chr11_-_33757872
|
0.610
|
NM_000611
NM_203329
NM_203330
NM_203331
|
CD59
|
CD59 molecule, complement regulatory protein
|
chr12_+_4430346
|
0.597
|
NM_020375
|
C12orf5
|
chromosome 12 open reading frame 5
|
chr7_-_151329153
|
0.592
|
NM_024429
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
chr8_-_29206321
|
0.571
|
NM_057158
|
DUSP4
|
dual specificity phosphatase 4
|
chr12_-_85306579
|
0.559
|
NM_001146335
NM_018057
NM_182767
|
SLC6A15
|
solute carrier family 6 (neutral amino acid transporter), member 15
|
chr8_-_29207795
|
0.558
|
NM_001394
|
DUSP4
|
dual specificity phosphatase 4
|
chr4_+_174089889
|
0.555
|
NM_017423
|
GALNT7
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7)
|
chr2_+_231578262
|
0.543
|
NM_001130849
NM_001130850
|
CAB39
|
calcium binding protein 39
|
chr1_+_178062829
|
0.540
|
NM_170692
|
RASAL2
|
RAS protein activator like 2
|
chr7_-_151511925
|
0.524
|
NM_001040633
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
chr12_+_75874512
|
0.523
|
NM_006851
|
GLIPR1
|
GLI pathogenesis-related 1
|
chr7_-_151574209
|
0.521
|
NM_016203
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
chr16_-_47177902
|
0.518
|
NM_001201477
NM_018092
|
NETO2
|
neuropilin (NRP) and tolloid (TLL)-like 2
|
chr3_-_120169493
|
0.517
|
NM_007085
|
FSTL1
|
follistatin-like 1
|
chr11_-_33744272
|
0.507
|
NM_001127223
NM_001127225
NM_001127226
|
CD59
|
CD59 molecule, complement regulatory protein
|
chr17_-_29641094
|
0.504
|
NM_006495
|
EVI2B
|
ecotropic viral integration site 2B
|
chr2_-_166650770
|
0.503
|
NM_004482
|
GALNT3
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3)
|
chrX_+_119737743
|
0.499
|
NM_014060
|
MCTS1
|
malignant T cell amplified sequence 1
|
chr11_-_33744497
|
0.497
|
NM_001127227
|
CD59
|
CD59 molecule, complement regulatory protein
|
chr14_-_99737821
|
0.492
|
NM_022898
NM_138576
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein)
|
chr2_+_231577536
|
0.491
|
NM_016289
|
CAB39
|
calcium binding protein 39
|
chr1_-_183604885
|
0.486
|
NM_005717
|
ARPC5
|
actin related protein 2/3 complex, subunit 5, 16kDa
|
chr12_-_51477299
|
0.480
|
NM_030809
|
CSRNP2
|
cysteine-serine-rich nuclear protein 2
|
chr9_+_35732207
|
0.479
|
NM_006368
|
CREB3
|
cAMP responsive element binding protein 3
|
chr12_-_110318178
|
0.472
|
NM_016433
|
GLTP
|
glycolipid transfer protein
|
chr3_-_113465101
|
0.471
|
NM_025146
|
NAA50
|
N(alpha)-acetyltransferase 50, NatE catalytic subunit
|
chr8_+_1772095
|
0.471
|
NM_014629
|
ARHGEF10
|
Rho guanine nucleotide exchange factor (GEF) 10
|
chr3_-_189840225
|
0.469
|
NM_001134418
|
LEPREL1
|
leprecan-like 1
|
chr3_+_150321065
|
0.466
|
NM_016275
|
SELT
|
selenoprotein T
|
chr9_-_27529434
|
0.463
|
NM_024761
|
MOB3B
|
MOB kinase activator 3B
|
chr12_+_32832128
|
0.460
|
NM_005690
NM_012062
NM_012063
|
DNM1L
|
dynamin 1-like
|
chr21_-_28339405
|
0.454
|
NM_007038
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
chr18_+_42260774
|
0.448
|
NM_015559
|
SETBP1
|
SET binding protein 1
|
chr12_-_44200047
|
0.446
|
NM_001242397
NM_002822
|
TWF1
|
twinfilin, actin-binding protein, homolog 1 (Drosophila)
|
chr4_+_75858205
|
0.439
|
NM_015393
|
PARM1
|
prostate androgen-regulated mucin-like protein 1
|
chr3_-_189838907
|
0.437
|
NM_018192
|
LEPREL1
|
leprecan-like 1
|
chr2_-_217560247
|
0.437
|
NM_000599
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
chr8_+_28351694
|
0.436
|
NM_017412
NM_145866
|
FZD3
|
frizzled family receptor 3
|
chr3_-_98620452
|
0.436
|
NM_080927
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2
|
chr8_+_15397595
|
0.434
|
NM_006765
NM_178234
|
TUSC3
|
tumor suppressor candidate 3
|
chr11_+_10476665
|
0.433
|
NM_001025389
|
AMPD3
|
adenosine monophosphate deaminase 3
|
chr22_-_45636584
|
0.433
|
NM_001009880
|
KIAA0930
|
KIAA0930
|
chr7_-_42276617
|
0.433
|
NM_000168
|
GLI3
|
GLI family zinc finger 3
|
chr1_-_184943673
|
0.428
|
NM_052966
|
FAM129A
|
family with sequence similarity 129, member A
|
chr4_+_88928797
|
0.426
|
NM_000297
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
chr15_+_63481713
|
0.418
|
NM_016530
|
RAB8B
|
RAB8B, member RAS oncogene family
|
chr1_-_201438150
|
0.414
|
NM_012396
|
PHLDA3
|
pleckstrin homology-like domain, family A, member 3
|
chr10_+_89419352
|
0.408
|
NM_001015880
NM_004670
|
PAPSS2
|
3'-phosphoadenosine 5'-phosphosulfate synthase 2
|
chr16_+_69220940
|
0.407
|
NM_006750
|
SNTB2
|
syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2)
|
chr5_+_149340287
|
0.403
|
NM_000112
|
SLC26A2
|
solute carrier family 26 (sulfate transporter), member 2
|
chr7_-_27135524
|
0.402
|
NM_005522
NM_153620
|
HOXA1
|
homeobox A1
|
chr13_-_21476895
|
0.402
|
NM_022459
|
XPO4
|
exportin 4
|
chr3_-_9291251
|
0.402
|
NM_001033117
NM_014850
|
SRGAP3
|
SLIT-ROBO Rho GTPase activating protein 3
|
chr5_-_9546157
|
0.401
|
NM_003966
|
SEMA5A
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
|
chr1_-_33168356
|
0.398
|
NM_001161708
NM_030786
|
SYNC
|
syncoilin, intermediate filament protein
|
chr12_-_54673901
|
0.398
|
NM_012117
|
CBX5
|
chromobox homolog 5
|
chr11_+_10482677
|
0.398
|
NM_001172430
|
AMPD3
|
adenosine monophosphate deaminase 3
|
chr1_-_52456292
|
0.395
|
NM_002867
|
RAB3B
|
RAB3B, member RAS oncogene family
|
chr8_-_24814028
|
0.395
|
NM_006158
|
NEFL
|
neurofilament, light polypeptide
|
chr4_+_72052354
|
0.393
|
NM_001098484
NM_001134742
|
SLC4A4
|
solute carrier family 4, sodium bicarbonate cotransporter, member 4
|
chr9_-_99801924
|
0.393
|
NM_001201575
|
CTSL2
|
cathepsin L2
|
chr6_-_169654047
|
0.389
|
NM_003247
|
THBS2
|
thrombospondin 2
|
chr5_-_57755787
|
0.388
|
NM_001252226
NM_006622
|
PLK2
|
polo-like kinase 2
|
chr1_+_218518675
|
0.386
|
NM_001135599
NM_003238
|
TGFB2
|
transforming growth factor, beta 2
|
chr1_+_145209067
|
0.385
|
NM_203458
|
NOTCH2NL
|
notch 2 N-terminal like
|
chr1_-_154832187
|
0.383
|
NM_170782
|
KCNN3
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
|
chr15_+_94841429
|
0.383
|
NM_001159643
NM_018349
|
MCTP2
|
multiple C2 domains, transmembrane 2
|
chr4_-_99579540
|
0.383
|
NM_005723
|
TSPAN5
|
tetraspanin 5
|
chr4_-_71705188
|
0.381
|
NM_001098477
|
GRSF1
|
G-rich RNA sequence binding factor 1
|
chr22_-_17646176
|
0.377
|
NM_017829
|
CECR5
|
cat eye syndrome chromosome region, candidate 5
|
chr18_-_45457454
|
0.376
|
NM_001003652
NM_001135937
|
SMAD2
|
SMAD family member 2
|
chr1_+_200708604
|
0.374
|
NM_203459
|
CAMSAP2
|
calmodulin regulated spectrin-associated protein family, member 2
|
chr13_-_37679800
|
0.370
|
NM_145203
|
CSNK1A1L
|
casein kinase 1, alpha 1-like
|
chr9_-_99801365
|
0.369
|
NM_001333
|
CTSL2
|
cathepsin L2
|
chr22_-_17640168
|
0.368
|
NM_033070
|
CECR5
|
cat eye syndrome chromosome region, candidate 5
|
chr4_-_185747183
|
0.362
|
NM_001995
|
ACSL1
|
acyl-CoA synthetase long-chain family member 1
|
chr6_+_143771779
|
0.361
|
NM_003630
|
PEX3
|
peroxisomal biogenesis factor 3
|
chr1_-_94147201
|
0.360
|
NM_003567
|
BCAR3
|
breast cancer anti-estrogen resistance 3
|
chr15_+_63569748
|
0.358
|
NM_001145646
NM_031301
|
APH1B
|
anterior pharynx defective 1 homolog B (C. elegans)
|
chr6_+_139456240
|
0.354
|
NM_016217
|
HECA
|
headcase homolog (Drosophila)
|
chr7_-_83824216
|
0.354
|
NM_006080
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
chr3_+_88188261
|
0.353
|
NM_018293
|
ZNF654
|
zinc finger protein 654
|
chr4_-_103245468
|
0.353
|
NM_001135148
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8
|
chr5_-_137368778
|
0.352
|
NM_001101800
NM_001101801
NM_016603
|
FAM13B
|
family with sequence similarity 13, member B
|
chrX_-_10645726
|
0.351
|
NM_001098624
|
MID1
|
midline 1 (Opitz/BBB syndrome)
|
chr3_-_125094003
|
0.351
|
NM_021964
|
ZNF148
|
zinc finger protein 148
|
chrX_-_34675366
|
0.349
|
NM_031442
|
TMEM47
|
transmembrane protein 47
|
chr6_-_137113624
|
0.349
|
NM_005923
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
chr4_-_40859081
|
0.348
|
NM_001166051
NM_001166052
NM_001166053
NM_001166054
|
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2
|
chrX_-_10544852
|
0.347
|
NM_001193277
|
MID1
|
midline 1 (Opitz/BBB syndrome)
|
chr5_+_82767492
|
0.346
|
NM_001126336
NM_001164097
NM_001164098
NM_004385
|
VCAN
|
versican
|
chr3_-_141719188
|
0.343
|
NM_001178140
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2)
|
chrX_-_10588458
|
0.343
|
NM_000381
NM_033289
|
MID1
|
midline 1 (Opitz/BBB syndrome)
|
chr5_-_83016850
|
0.342
|
NM_001884
|
HAPLN1
|
hyaluronan and proteoglycan link protein 1
|
chr11_+_10471867
|
0.337
|
NM_001172431
|
AMPD3
|
adenosine monophosphate deaminase 3
|
chr1_-_185286460
|
0.336
|
NM_006469
|
IVNS1ABP
|
influenza virus NS1A binding protein
|
chr20_-_57617836
|
0.332
|
NM_016045
|
SLMO2
|
slowmo homolog 2 (Drosophila)
|
chr12_-_109125289
|
0.332
|
NM_014325
|
CORO1C
|
coronin, actin binding protein, 1C
|
chr1_-_186649421
|
0.330
|
NM_000963
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
chr20_+_56884749
|
0.329
|
NM_020673
|
RAB22A
|
RAB22A, member RAS oncogene family
|
chr11_-_14380591
|
0.327
|
NM_012250
|
RRAS2
|
related RAS viral (r-ras) oncogene homolog 2
|
chr3_-_45187897
|
0.326
|
NM_022842
NM_178181
|
CDCP1
|
CUB domain containing protein 1
|
chr4_+_154125589
|
0.325
|
NM_015271
|
TRIM2
|
tripartite motif containing 2
|
chr5_-_132299263
|
0.324
|
NM_014423
|
AFF4
|
AF4/FMR2 family, member 4
|
chr4_-_70826712
|
0.323
|
NM_001891
|
CSN2
|
casein beta
|
chr15_+_32933869
|
0.323
|
NM_001144757
NM_003020
|
SCG5
|
secretogranin V (7B2 protein)
|
chr2_-_227663454
|
0.319
|
NM_005544
|
IRS1
|
insulin receptor substrate 1
|
chr3_+_133293256
|
0.317
|
NM_001134423
|
CDV3
|
CDV3 homolog (mouse)
|
chr11_-_14380030
|
0.317
|
NM_001177315
NM_001102669
|
RRAS2
|
related RAS viral (r-ras) oncogene homolog 2
|
chr4_-_41216455
|
0.317
|
NM_001166050
NM_004307
NM_173075
|
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2
|
chr12_-_21654484
|
0.316
|
NM_002907
NM_032941
|
RECQL
|
RecQ protein-like (DNA helicase Q1-like)
|
chrX_-_10851808
|
0.316
|
NM_033290
|
MID1
|
midline 1 (Opitz/BBB syndrome)
|
chr1_+_13911966
|
0.315
|
NM_001006624
NM_001006625
|
PDPN
|
podoplanin
|
chr8_-_67525426
|
0.314
|
NM_001080416
NM_001144755
|
MYBL1
LOC645895
|
v-myb myeloblastosis viral oncogene homolog (avian)-like 1
uncharacterized LOC645895
|
chr3_+_133292404
|
0.312
|
NM_001134422
NM_017548
|
CDV3
|
CDV3 homolog (mouse)
|
chr2_+_191745546
|
0.312
|
NM_014905
|
GLS
|
glutaminase
|
chr7_+_114562140
|
0.312
|
NM_001166345
NM_001166346
NM_199072
|
MDFIC
|
MyoD family inhibitor domain containing
|
chr1_+_101702304
|
0.312
|
NM_001400
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
chr9_-_19786886
|
0.311
|
NM_001193288
NM_020344
|
SLC24A2
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2
|
chrX_+_135251454
|
0.310
|
NM_001159704
|
FHL1
|
four and a half LIM domains 1
|
chr7_+_18126543
|
0.310
|
NM_001204144
|
HDAC9
|
histone deacetylase 9
|
chr3_+_36421944
|
0.310
|
NM_003149
|
STAC
|
SH3 and cysteine rich domain
|
chr11_-_14386051
|
0.309
|
NM_001177314
|
RRAS2
|
related RAS viral (r-ras) oncogene homolog 2
|
chr10_+_91152321
|
0.307
|
NM_001548
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1
|
chr5_+_140797243
|
0.307
|
NM_018927
|
PCDHGB7
|
protocadherin gamma subfamily B, 7
|
chr4_-_114900802
|
0.305
|
NM_024590
|
ARSJ
|
arylsulfatase family, member J
|
chr6_+_125475334
|
0.304
|
NM_001003395
|
TPD52L1
|
tumor protein D52-like 1
|
chr5_-_79286793
|
0.303
|
NM_001010891
NM_001167741
|
MTX3
|
metaxin 3
|
chr10_-_105677986
|
0.303
|
NM_024928
|
OBFC1
|
oligonucleotide/oligosaccharide-binding fold containing 1
|
chr2_-_9771101
|
0.301
|
NM_006826
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide
|
chr8_-_25315941
|
0.300
|
NM_017634
|
KCTD9
|
potassium channel tetramerisation domain containing 9
|
chr5_+_32710742
|
0.300
|
NM_001204376
|
NPR3
|
natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C)
|
chr1_+_192778168
|
0.300
|
NM_002923
|
RGS2
|
regulator of G-protein signaling 2, 24kDa
|
chr21_-_19191643
|
0.299
|
NM_001100420
NM_001100421
NM_017447
|
C21orf91
|
chromosome 21 open reading frame 91
|
chr1_-_154842725
|
0.297
|
NM_001204087
NM_002249
|
KCNN3
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
|
chr4_+_52709165
|
0.297
|
NM_001040402
NM_015115
|
DCUN1D4
|
DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae)
|
chr6_+_125474800
|
0.295
|
NM_001003396
NM_001003397
NM_003287
|
TPD52L1
|
tumor protein D52-like 1
|
chr11_+_10472223
|
0.293
|
NM_000480
|
AMPD3
|
adenosine monophosphate deaminase 3
|
chr18_-_45456925
|
0.292
|
NM_005901
|
SMAD2
|
SMAD family member 2
|
chr12_-_8815370
|
0.292
|
NM_003480
|
MFAP5
|
microfibrillar associated protein 5
|
chr22_-_45608346
|
0.290
|
NM_015264
|
KIAA0930
|
KIAA0930
|
chr5_-_127873734
|
0.290
|
NM_001999
|
FBN2
|
fibrillin 2
|
chr1_+_213123853
|
0.290
|
NM_001136474
NM_001136475
NM_024749
|
VASH2
|
vasohibin 2
|